Paul J. Zwier II

zwierPaul J. Zwier II
Of Counsel

Phone: (404) 712-2358

Practice Areas
Whistleblower and False Claims
High Impact Litigation
Employment Litigation
Corporate Governance

Professor of law and director of the Center for Advocacy and Dispute Resolution, University of Tennessee


Pepperdine University (J.D., 1979)
Temple University (LLM, 1981)
Calvin College (B.A., 1976)



Faculty, Emory Law School
Former Drector, Public Education, National Institute for Trial Advocacy
Consultant, the Carter Center
Lawyers Without Borders

President Obama’s Supreme Court nominee has a history of siding with health agencies

The Food and Drug Administration and other public health agencies will likely be pleased by President Barack Obama’s nomination Wednesday of Merrick Garland to the Supreme Court.

That’s because Garland, currently chief judge on the US Court of Appeals in Washington, D.C., is known for backing federal agencies like FDA and the Environmental Protection Agency against legal challenges on health-related cases.

Read the full article on

Justin S. Brooks

j brooks bio pageJustin S. Brooks
Founding Partner

(302) 327-9210

Practice Areas
Whistleblower and False Claims
High Impact Litigation
Employment Litigation
Corporate Governance

Government Experience
Law Clerk, Hon. Suzanne B. Conlon, U.S. District Court, Northern District of Illinois

University of Michigan Law School (J.D., cum laude, 2008)
Emory University (B.A., Psychology, 2005)

Commonwealth of Pennsylvania
State of New York
State of Delaware
The U.S. District Courts for the
– Eastern District of Pennsylvania
– Southern District of New York
– Eastern District of New York

Anti-Defamation League
Jewish Federation of Greater Philadelphia
Lawyers Without Borders

Doctors promoting treatments on social media routinely fail to disclose ties to drug makers

by Sheila Kaplan (

Washington – Physicians across the United States routinely offer medical advice on social media — but often fail to mention that they have accepted tens and sometimes hundreds of thousands of dollars from the companies that make the prescription drugs they tout.

A STAT examination of hundreds of social media accounts shows that health care professionals virtually never note their conflicts of interest, some of them significant, when promoting drugs or medical devices on sites such as Facebook, Instagram, and Twitter. The practice cuts across all specialties.

. . .

But Reuben Guttman, an attorney in Washington who specializes in food and drug law, said the system leaves patients vulnerable to misinformation.

“Doctors who accept these dollars and then turn around and promote on social media corrupt the market for honest medical information,” Guttman said. “And drug companies that pay these doctors are similarly poisoning the market for honest information.”

Read the full article at

A Failure of Remedies: The Case of Big Pharma (An Essay)

By Paul J. Zwier and Reuben Guttman
Emory Corporate Governance and Accountability Review
Emory Law

This Article examines the U.S. pharmaceutical industry and the harms imposed on individual patients and healthcare consumers—including private and government third party payers—from practices proscribed by Federal and State laws regulating marketing and pricing. 1

The Article pays particular attention to the False Claims Act (FCA), which has become the government’s primary civil weapon against fraudulent and/or wrongful conduct causing the expenditure of government dollars.
Read the entire Essay at